E3 Continuous Glucose Monitoring System
LBL-4003-01-001, E3, Continuous Glucose Monitoring System, E3 Continuous Glucose Monitoring System, Glucose Monitoring System, Monitoring System
Eversense offers the world’s first long-term implantable continuous glucose monitoring (CGM) systems, providing diabetes patients with sensor readings for up to 6 months.
Selected manuals from manuals+ curated for this brand.
Additional documents are a limited selection. Search all manuals.